These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 10920922

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
    Ji SQ, Hua YW, Zhuang J, Gao Y, Kong Y, Han SL, Shao YF.
    Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
    [Abstract] [Full Text] [Related]

  • 4. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
    Liu L, Yang K.
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):101-4. PubMed ID: 11263193
    [Abstract] [Full Text] [Related]

  • 5. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT, Wu MS, Lin JT, Chen SY, Wang HP, Lee WJ, Wang TH, Chuang SM.
    Hepatogastroenterology; 1997 Feb; 44(14):604-9. PubMed ID: 9164544
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
    Krause FS, Feil G, Bichler KH.
    Anticancer Res; 2000 Feb; 20(6D):5023-8. PubMed ID: 11326661
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical significance of nm23 gene expression in gastric cancer.
    Mönig SP, Nolden B, Lübke T, Pohl A, Grass G, Schneider PM, Dienes HP, Hölscher AH, Baldus SE.
    Anticancer Res; 2007 Feb; 27(4C):3029-33. PubMed ID: 17695492
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V, Migliavacca M, Zanna I, Tubiolo C, Corsale S, Calò V, Amato A, Cammareri P, Latteri F, Grassi N, Fulfaro F, Porcasi R, Morello V, Nuara RB, Dardanoni G, Salerno S, Valerio MR, Dusonchet L, Gerbino A, Gebbia N, Tomasino RM, Russo A.
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [Abstract] [Full Text] [Related]

  • 15. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
    Oda Y, Naka T, Takeshita M, Iwamoto Y, Tsuneyoshi M.
    Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunohistochemical analysis of nm23-H1 protein in bladder cancer.
    Kuo JY, Chiang H, Chen KK, Chang LS.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):411-7. PubMed ID: 10418173
    [Abstract] [Full Text] [Related]

  • 20. Correlation of MDR1 expression and oncogenic activation in human epithelial ovarian carcinoma.
    Schneider J, Centeno M, Jimenez E, Rodriguez-Escudero FJ, Romero H.
    Anticancer Res; 1997 Jul; 17(3C):2147-51. PubMed ID: 9216679
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.